Synovus Financial’s NuVasive, Inc. NUVA Stock Holding History

Synovus Financial’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,628	Closed	-$224K	–	778
2020 Q3	$224K	Buy	4,628 +178	+4%	+$9.59K	﹤0.01%	659
2020 Q2	$247K	Buy	4,450 +461	+12%	+$26.7K	﹤0.01%	608
2020 Q1	$207K	Buy	3,989 +329	+9%	+$22.1K	﹤0.01%	760
2019 Q4	$280K	Buy	3,660 +175	+5%	+$12.4K	﹤0.01%	611
2019 Q3	$225K	Buy	3,485 +3,397	+3,860%	+$212K	﹤0.01%	633
2019 Q2	$5K	Hold	88	–	–	﹤0.01%	1233
2019 Q1	$5K	Hold	88	–	–	﹤0.01%	1230
2018 Q4	$4K	Hold	88	–	–	﹤0.01%	1249
2018 Q3	$6K	Buy	+88	New	+$5.6K	﹤0.01%	1217
2017 Q2	–	Sell	-68	Closed	-$5K	–	1151
2017 Q1	$5K	Buy	+68	New	+$4.93K	﹤0.01%	1024

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Synovus Financial's NUVA Position: Q4 2020 in Review

Synovus Financial sold out of NuVasive, Inc. (NUVA) in Q4 2020, closing a stake of 4,628 shares — an estimated $224K sold.

Synovus Financial first reported a position in NUVA in Q1 2017 and held it in 10 quarters. The position peaked at $280K in Q4 2019. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

Synovus Financial reported no remaining NuVasive, Inc. position as of Q4 2020 after selling out during the quarter.
Synovus Financial sold 4,628 NuVasive, Inc. shares in Q4 2020, an estimated $224K.
Synovus Financial first reported a position in NuVasive, Inc. in Q1 2017 and held it in 10 quarters.
Synovus Financial's NuVasive, Inc. position peaked at $280K in Q4 2019.
280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Synovus Financial's 13F filing for Q4 2020, filed 11 Feb 2021.